Vildagliptin & Metformin HCL (SR) Tablets 50/500 mg

Uses of Vildagliptin & Metformin HCL (SR) Tablets 50/500 mg

This medication is prescribed for adults with type 2 diabetes mellitus to:

• Improve blood sugar control in conjunction with diet and exercise.
• Lower the risk of diabetes-related complications.
• Serve as an adjunct to diet and exercise in patients not adequately controlled on their maximal tolerated dose of metformin alone.

Benefits of Vildagliptin & Metformin HCL (SR) Tablets 50/500 mg

• Effective in lowering blood sugar levels.
• Helps in achieving better glycemic control.
• Reduces the risk of diabetes-related complications.
• The sustained release (SR) formula ensures a gradual release of the medication, aiding in better tolerance and minimizing gastrointestinal side effects.

Side Effects of Vildagliptin & Metformin HCL (SR) Tablets 50/500 mg

Common side effects may include:

• Nausea
• Vomiting
• Diarrhea
• Headache
• Nasopharyngitis

Note: This is not an exhaustive list. Some individuals may experience other side effects. Consult your healthcare provider for a complete list of side effects.

How to Use Vildagliptin & Metformin HCL (SR) Tablets 50/500 mg

• Take this medication as prescribed by your healthcare provider.
• It is usually taken once or twice daily with meals to reduce gastrointestinal side effects.
• Swallow the tablet whole with water, without crushing or chewing.

How Vildagliptin & Metformin HCL (SR) Tablets 50/500 mg Works

Vildagliptin works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. Metformin works by decreasing glucose production in the liver, delaying glucose absorption from the intestines, and improving insulin sensitivity. This combination effectively lowers blood sugar levels.

Storage

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children and pets.

Caution and Warning

• Not for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
• Not recommended for use in patients with severe renal impairment.
• Regular monitoring of renal function is recommended.
• Inform your healthcare provider about all other medications you are taking to avoid potential interactions.
• If you experience symptoms of hypoglycemia, such as dizziness, sweating, or palpitations, inform your healthcare provider.